165 related articles for article (PubMed ID: 30477458)
1. Cetuximab for esophageal cancer: an updated meta-analysis of randomized controlled trials.
Huang ZH; Ma XW; Zhang J; Li X; Lai NL; Zhang SX
BMC Cancer; 2018 Nov; 18(1):1170. PubMed ID: 30477458
[TBL] [Abstract][Full Text] [Related]
2. Cetuximab in combination with chemoradiotherapy for nasopharyngeal carcinoma: A meta-analysis.
Wang N; Wang K; Song F; Liu Y
Indian J Cancer; 2018; 55(2):196-200. PubMed ID: 30604736
[TBL] [Abstract][Full Text] [Related]
3. Cetuximab in patients with esophageal cancer: a systematic review and meta-analysis of randomized controlled trials.
Tian X; Zhou JG; Zeng Z; Shuai T; Yi LJ; Ma L; Wang Y; Cao H; Song GM
Med Oncol; 2015 Apr; 32(4):127. PubMed ID: 25794489
[TBL] [Abstract][Full Text] [Related]
4. Standard chemotherapy with cetuximab for treatment of colorectal cancer.
Li XX; Liang L; Huang LY; Cai SJ
World J Gastroenterol; 2015 Jun; 21(22):7022-35. PubMed ID: 26078581
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of clinical trials over regimens with or without cetuximab for advanced gastric cancer patients.
Ji L; Gu D; Tan X; Sun H; Chen J
J BUON; 2017; 22(4):900-904. PubMed ID: 29155518
[TBL] [Abstract][Full Text] [Related]
6. Cetuximab in Pancreatic Cancer Therapy: A Systematic Review and Meta-Analysis.
Forster T; Huettner FJ; Springfeld C; Loehr M; Kalkum E; Hackbusch M; Hackert T; Diener MK; Probst P
Oncology; 2020; 98(1):53-60. PubMed ID: 31578019
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemotherapy for resectable thoracic esophageal cancer.
Malthaner R; Fenlon D
Cochrane Database Syst Rev; 2001; (1):CD001556. PubMed ID: 11279723
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab combined with chemotherapy for ovarian cancer: an updated systematic review and meta-analysis of randomized controlled trials.
Wu YS; Shui L; Shen D; Chen X
Oncotarget; 2017 Feb; 8(6):10703-10713. PubMed ID: 27793044
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of cetuximab-related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: results from a randomized trial of the GERMAN AIO CRC Study Group.
Stintzing S; Kapaun C; Laubender RP; Jung A; Neumann J; Modest DP; Giessen C; Moosmann N; Wollenberg A; Kirchner T; Heinemann V
Int J Cancer; 2013 Jan; 132(1):236-45. PubMed ID: 22644776
[TBL] [Abstract][Full Text] [Related]
10. Concomitant platinum-based chemotherapy or cetuximab with radiotherapy for locally advanced head and neck cancer: a systematic review and meta-analysis of published studies.
Petrelli F; Coinu A; Riboldi V; Borgonovo K; Ghilardi M; Cabiddu M; Lonati V; Sarti E; Barni S
Oral Oncol; 2014 Nov; 50(11):1041-8. PubMed ID: 25176576
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of short-term effectiveness of eight targeted agents combined with chemotherapy for treating esophageal-gastric junction adenocarcinoma: A network meta-analysis.
He YM; Yu C; Li WB; Li ZP; Xu N
J Cell Biochem; 2018 Jan; 119(1):1183-1192. PubMed ID: 28708307
[TBL] [Abstract][Full Text] [Related]
12. Concurrent chemo-radiotherapy with S-1 as an alternative therapy for elderly Chinese patients with non-metastatic esophageal squamous cancer: evidence based on a systematic review and meta-analysis.
Song GM; Tian X; Liu XL; Chen H; Zhou JG; Bian W; Chen WQ
Oncotarget; 2017 Jun; 8(23):37963-37973. PubMed ID: 28415814
[TBL] [Abstract][Full Text] [Related]
13. Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2).
Rades D; Bartscht T; Hunold P; Schmidberger H; König L; Debus J; Belka C; Homann N; Spillner P; Petersen C; Kuhnt T; Fietkau R; Ridwelski K; Karcher-Kilian K; Kranich A; Männikkö S; Schild SE; Maderer A; Moehler M
Strahlenther Onkol; 2020 Sep; 196(9):795-804. PubMed ID: 32533228
[TBL] [Abstract][Full Text] [Related]
14. Cetuximab versus nimotuzumab for the treatment of advanced nasopharyngeal carcinoma: A network meta-analysis.
Yuan C; Xu XH; Xu L; Liu Y; Sun M; Ni LH; Wang XL; Chen Z; Zhang K; Wan HL; Zeng G
J BUON; 2017; 22(4):1004-1010. PubMed ID: 28952220
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant therapy of cetuximab combined with chemoradiotherapy in rectal cancer: A single-arm meta-analysis of noncomparative clinical studies and randomized controlled trials.
Yan Q; Zhu JJ; Zhao FM; Shu QJ; Chen SY
Medicine (Baltimore); 2021 Feb; 100(7):e24649. PubMed ID: 33607800
[TBL] [Abstract][Full Text] [Related]
16. [Cetuximab in head and neck squamous cell carcinoma: a systematic review and Meta-analysis].
Song Q; Li X; Li B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(1):67-75. PubMed ID: 25966559
[TBL] [Abstract][Full Text] [Related]
17. Impact of Primary Tumor Location on First-line Bevacizumab or Cetuximab in Metastatic Colorectal Cancer.
Snyder M; Bottiglieri S; Almhanna K
Rev Recent Clin Trials; 2018; 13(2):139-149. PubMed ID: 29595113
[TBL] [Abstract][Full Text] [Related]
18. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B; Kremer LC; Caron HN; van Dalen EC
Cochrane Database Syst Rev; 2013 Aug; (8):CD006301. PubMed ID: 23970444
[TBL] [Abstract][Full Text] [Related]
19. The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation.
Huxley N; Crathorne L; Varley-Campbell J; Tikhonova I; Snowsill T; Briscoe S; Peters J; Bond M; Napier M; Hoyle M
Health Technol Assess; 2017 Jun; 21(38):1-294. PubMed ID: 28682222
[TBL] [Abstract][Full Text] [Related]
20. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus.
Rebecca WO; Richard MA
Cochrane Database Syst Rev; 2003; (1):CD002092. PubMed ID: 12535428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
